[2O09m-2] 運動ニューロン疾患など

[2O09m-2-2] Targeting FUS phase separation with oligonucleotides for ALS/FTLD therapy

*Mohammad Moniruzzaman¹, Yusuke Fujioka¹, Akihide Takeuchi², Akio Masuda³, Shinobu Hirai⁴, Masahiro Neya⁵, Yohei Okada⁶, Shinsuke Ishigaki¹ (1. Mol. Neurosci. Ctr., Shiga Univ. of Med. Sci. , 2. Dept. of Dev. Biol. and Func. Genomics, Ehime Univ. Grad. Sch. of Med. , 3. Car. for Neurol. Dis and Cancer, Nagoya Univ. Grad. Sch. of Med. , 4. Dept. of Psych. and Behav. Sci., Tokyo Metro. Inst. of med. Sci. , 5. KNC Lab. Co., Ltd. , 6. Inst. for Med. Sci. of Aging., Aichi Med. Univ.)

キーワード：

ALS、Fused in sarcoma (FUS)、Oligonucleotides、LLPS

閲覧にはパスワードが必要です